Search research articles
Contact Us
Filters
Showing results (81-90 of 98) with videos related to
Page
of 10
Sort By:
The Journal of Urology
|
March 18, 2021
Reply by Authors
Dennie Meijer, Hilda A de Barros, Pim J van Leeuwen, et al.
The Journal of Urology
|
February 3, 2021
The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer
Dennie Meijer, Hilda A de Barros, Pim J van Leeuwen, et al.
EJNMMI Research
|
July 16, 2025
[<sup>195m</sup>Pt]Cisplatin for lung cancer imaging: a pilot study
Denise S Hoogenkamp, Berlinda J de Wit-van der Veen, Jeske Hendriksen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Management impact of <sup>18</sup>F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study
Dennie Meijer, Pim J van Leeuwen, Pepijn M J Oosterholt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Quantification of PD-L1 Expression with <sup>18</sup>F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Marc C Huisman, Anna-Larissa N Niemeijer, Albert D Windhorst, et al.
Cancer Cell
|
January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
Astrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography
Astrid A M van der Veldt, Mark Lubberink, Ron H J Mathijssen, et al.
Clinical Pharmacokinetics
|
September 18, 2014
Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept
Miriam G Mooij, Esther van Duijn, Catherijne A J Knibbe, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification
Suzanne van der Gaag, Tamara Jordens, Maqsood Yaqub, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 98) with videos related to
Sort By:
Page
of 10
The Journal of Urology
|
March 18, 2021
Reply by Authors
Dennie Meijer, Hilda A de Barros, Pim J van Leeuwen, et al.
The Journal of Urology
|
February 3, 2021
The Predictive Value of Preoperative Negative Prostate Specific Membrane Antigen Positron Emission Tomography Imaging for Lymph Node Metastatic Prostate Cancer
Dennie Meijer, Hilda A de Barros, Pim J van Leeuwen, et al.
EJNMMI Research
|
July 16, 2025
[<sup>195m</sup>Pt]Cisplatin for lung cancer imaging: a pilot study
Denise S Hoogenkamp, Berlinda J de Wit-van der Veen, Jeske Hendriksen, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
February 6, 2021
Management impact of <sup>18</sup>F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study
Dennie Meijer, Pim J van Leeuwen, Pepijn M J Oosterholt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 16, 2020
Quantification of PD-L1 Expression with <sup>18</sup>F-BMS-986192 PET/CT in Patients with Advanced-Stage Non-Small Cell Lung Cancer
Marc C Huisman, Anna-Larissa N Niemeijer, Albert D Windhorst, et al.
Cancer Cell
|
January 24, 2012
Rapid decrease in delivery of chemotherapy to tumors after anti-VEGF therapy: implications for scheduling of anti-angiogenic drugs
Astrid A M Van der Veldt, Mark Lubberink, Idris Bahce, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
December 5, 2020
Phase I Trial of <sup>131</sup>I-GMIB-Anti-HER2-VHH1, a New Promising Candidate for HER2-Targeted Radionuclide Therapy in Breast Cancer Patients
Matthias D'Huyvetter, Jens De Vos, Vicky Caveliers, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Toward prediction of efficacy of chemotherapy: a proof of concept study in lung cancer patients using [¹¹C]docetaxel and positron emission tomography
Astrid A M van der Veldt, Mark Lubberink, Ron H J Mathijssen, et al.
Clinical Pharmacokinetics
|
September 18, 2014
Pediatric microdose study of [(14)C]paracetamol to study drug metabolism using accelerated mass spectrometry: proof of concept
Miriam G Mooij, Esther van Duijn, Catherijne A J Knibbe, et al.
CPT: Pharmacometrics & Systems Pharmacology
|
February 26, 2025
Physiologically Based Pharmacokinetic Model of Tyrosine Kinase Inhibitors to Predict Target Site Penetration, with PET-Guided Verification
Suzanne van der Gaag, Tamara Jordens, Maqsood Yaqub, et al.
Page
of 10